← Leaderboards
John C Curtis
University Of Alabama At Birmingham
$433,062
Attributed
$433,062
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$433,062 · 3
By mechanism
M01$433,062 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Anupam Agarwal$17,840,868
- Judith M. Thomas$6,258,648
- Majd Zayzafoon$4,514,421
- Frances E. Lund$38,753,426
- Craig A Elmets$8,601,504
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCyclosporinesHuman SubjectHuman Therapy EvaluationKidney TransplantationKidney Disorder ChemotherapyMycophenolic AcidDosageImmunosuppressionCombination ChemotherapyPrednisoneOral AdministrationPharmacokineticsDosage FormsDrug Screening /EvaluationGastrointestinal Absorption /TransportGastrointestinal Drug AbsorptionTransplant RejectionPatient Oriented ResearchDrug Adverse Effect
Grant awards (6)
EXPLORATION OF C-2 LEVELS IN MAINTENANCE PHASE RENAL TRANSPLANT PATIENTS$7,995
M01 · FY2005 · RR
C-2 Levels in Maintenance Phase Renal Transplant Patient$15,497
M01 · FY2004 · RR
EFFECTS OF DECREASED CYCLOSPORINE DOSING$175,256
M01 · FY2002 · RR
EFFECTS OF DECREASED CYCLOSPORINE DOSING$175,256
M01 · FY2001 · RR
BIOAVAILABLITY IN FASTING OF SANDIMMUNE ORAL SOLUTION VS SOFT GELATIN CAPSULES$29,529
M01 · FY2000 · RR
EFFECTS OF DECREASED CYCLOSPORINE DOSING$29,529
M01 · FY2000 · RR